![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/JLHL.png)
Share the post "Jupiter Life Line Hospitals ‘s Q3 2024-25 Latest News: Revenue Rises by 17.62% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 17.62 % in the past year, decrease in net sales/revenue by -0.6 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 5 %. Marginal decrease of -12.06% in other income during this quarter. 🔹 Profit over the Year and quarter: Significant improvement in profitability for Jupiter Life Line Hospitals Limited. Notable increase of 20.26 % in net profit Year to Year, Jupiter Life Line Hospitals Limited’s profitability increased by 1.95 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 22.10 % Year to Year. EPS increased by 1.91 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 272.613 Cr | Rs. 322.578 Cr | Rs. 320.638 Cr | -0.6 % | + 17.62 % |
| Expenses | Rs. 210.76 Cr | Rs. 247.59 Cr | Rs. 245.63 Cr | -0.79 % | + 16.54 % |
| Operating Profit | Rs. 61.85 Cr | Rs. 74.99 Cr | Rs. 75.01 Cr | + 0.03 % | + 21.28 % |
| OPM % | 22.69 % | 23.25 % | 23.39 % | + 0.14 % | + 0.7 % |
| Other Income | Rs. 7.906 Cr | Rs. 9.439 Cr | Rs. 8.301 Cr | -12.06 % | + 5 % |
| Interest | Rs. 1.03 Cr | Rs. 1.12 Cr | Rs. 2.78 Cr | + 148.21 % | + 169.9 % |
| Depreciation | Rs. 10.65 Cr | Rs. 14.4 Cr | Rs. 13.97 Cr | -2.99 % | + 31.17 % |
| Profit before tax | Rs. 58.08 Cr | Rs. 68.91 Cr | Rs. 66.56 Cr | -3.41 % | + 14.6 % |
| Tax % | 24.82 % | 25.25 % | 21.1 % | -4.15 % | -3.72 % |
| Net Profit | Rs. 43.67 Cr | Rs. 51.51 Cr | Rs. 52.51 Cr | + 1.94 % | + 20.24 % |
| EPS in Rs | Rs. 6.56 | Rs. 7.86 | Rs. 8.01 | + 1.91 % | + 22.1 % |
Today, we’re looking at Jupiter Life Line Hospitals Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 17.62 %. However, it did see a marginal slip of -0.6 % from the previous quarter. Expenses decreased slightly by -0.79 % quarter-on-quarter, aligning with the annual rise of 16.54 %. Operating profit, while up 21.28 % compared to last year, faced a quarter-on-quarter increase of 0.03 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.7 %, but an expansion of 0.14 % sequentially. Other income fell by -12.06 % compared to the last quarter, despite an annual growth of 5 %. Interest expenses surged remarkably by 148.21 % from the previous quarter, yet the year-over-year increase remains at a moderate 169.9 %. Depreciation costs fell by -2.99 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 31.17 %. Profit before tax grew annually by 14.6 % but saw a reduction from the preceding quarter by -3.41 %.
Tax expenses as a percentage of profits decreased slightly by -3.72 % compared to last year, with a more notable quarter-on-quarter decrease of -4.15 %. Net profit rose by 20.24 % year-on-year but experienced a 1.94 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 22.1 % but a quarterly rise of 1.91 %. In summary, Jupiter Life Line Hospitals Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 272.613 Cr | Rs. 322.578 Cr | Rs. 320.638 Cr | -0.6 % | + 17.62 % |
| Expenses | Rs. 210.76 Cr | Rs. 247.59 Cr | Rs. 245.63 Cr | -0.79 % | + 16.54 % |
| Operating Profit | Rs. 61.85 Cr | Rs. 74.99 Cr | Rs. 75.01 Cr | + 0.03 % | + 21.28 % |
| Net Profit | Rs. 43.67 Cr | Rs. 51.51 Cr | Rs. 52.51 Cr | + 1.94 % | + 20.24 % |
| EPS in Rs | Rs. 6.56 | Rs. 7.86 | Rs. 8.01 | + 1.91 % | + 22.1 % |
In reviewing Jupiter Life Line Hospitals Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 17.62 % year-on-year growth, although there was a slight dip of -0.6 % from the previous quarter. Expenses rose by 16.54 % compared to the previous year, with a decrease of -0.79 % quarter-on-quarter. Operating Profit surged by 21.28 % annually, and saw a 0.03 % increase from the last quarter.
Net Profit showed yearly increase of 20.24 %, and experienced a 1.94 % increase from the previous quarter. Earnings Per Share (EPS) rose by 22.1 % annually, however rose by 1.91 % compared to the last quarter. In essence, while Jupiter Life Line Hospitals Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SABTNL.png)
